This article is from the source 'rtcom' and was first published or seen on . It last changed over 40 days ago and won't be checked again for changes.

You can find the current article at its original source at https://www.rt.com/news/526321-eu-approves-new-moderna-site-france/

The article has changed 3 times. There is an RSS feed of changes available.

Version 1 Version 2
EU drugs regulator approves new site for manufacture of Moderna Covid-19 vaccine in France EU drugs regulator approves new site for manufacture of Moderna Covid-19 vaccine in France
(about 1 month later)
The European Medicines Agency (EMA) has approved a new manufacturing plant in central France to boost production of the Moderna Covid-19 vaccine, the regulator’s committee for human medicines has said.The European Medicines Agency (EMA) has approved a new manufacturing plant in central France to boost production of the Moderna Covid-19 vaccine, the regulator’s committee for human medicines has said.
The new site will be in Monts near the Loire Valley town of Tours and will be operated by pharmaceutical manufacturer Recipharm, the EMA said in a statement on Friday.The new site will be in Monts near the Loire Valley town of Tours and will be operated by pharmaceutical manufacturer Recipharm, the EMA said in a statement on Friday.
The Sweden-headquartered firm already has a facility in Monts for the filling of pharmaceutical products into vials.The Sweden-headquartered firm already has a facility in Monts for the filling of pharmaceutical products into vials.
As well as a new manufacturing facility for the Moderna jab, the EMA said it has issued a “positive opinion” for alternative batch control and testing sites.As well as a new manufacturing facility for the Moderna jab, the EMA said it has issued a “positive opinion” for alternative batch control and testing sites.
Last week the regulator approved two new US sites for manufacturing the active substance and finished product of the US-developed Moderna jab.Last week the regulator approved two new US sites for manufacturing the active substance and finished product of the US-developed Moderna jab.
The EMA said it expects the approvals of the three sites to result in an extra 1 or 2 million vials of vaccine becoming available for the EU each month.The EMA said it expects the approvals of the three sites to result in an extra 1 or 2 million vials of vaccine becoming available for the EU each month.
In February the EU’s European Commission announced it had signed a deal with Moderna for an additional 150 million doses of its vaccine this year with the option to purchase another 150 million in 2022.In February the EU’s European Commission announced it had signed a deal with Moderna for an additional 150 million doses of its vaccine this year with the option to purchase another 150 million in 2022.
Think your friends would be interested? Share this story!Think your friends would be interested? Share this story!
Dear readers and commenters,
We have implemented a new engine for our comment section. We hope the transition goes smoothly for all of you. Unfortunately, the comments made before the change have been lost due to a technical problem. We are working on restoring them, and hoping to see you fill up the comment section with new ones. You should still be able to log in to comment using your social-media profiles, but if you signed up under an RT profile before, you are invited to create a new profile with the new commenting system.
Sorry for the inconvenience, and looking forward to your future comments,
RT Team.